Founded in 1986, Cranial Technologies is a developer, manufacturer, and provider of custom cranial orthotics dedicated to treating infants with plagiocephaly - a common condition that affects nearly half of all babies born each year. Cranial Technologies manufactures the DOC Band®, a custom cranial orthotic, and maintains a growing network of over 80 dedicated clinics across the United States.

BPOC Value Add

Proactive Sourcing

BPOC was introduced to the company in 2012 and developed an investment thesis leveraging previous experiences in medical products and multi-site provider businesses.

Invest in People

BPOC recruited a new CEO to facilitate the planned retirement of CEO at the time of BPOC’s investment. In addition, BPOC augmented the management team through several key additions, including Chief Financial Officer, Chief Clinical Officer, VP of Operations, VP of Manufacturing, and multiple regional clinical leaders.

Design to Scale

BPOC supported the development of infrastructure required to accelerate new clinic openings, including site selection, payor contracting, and marketing processes to drive new markets referrals. These investments allowed Cranial to increase new clinic openings from three per year to over 16 per year through out BPOC's Investment.

Implement Operating Improvements

Since BPOC’s investment, Cranial has made significant investments in streamlining and automating manufacturing processes, including 3D printing capabilities. Also, Cranial has implemented best practices across all locations to ensure clinical efficacy, safety, and improved compliance protocols. In addition to investing in manufacturing capacity and capabilities (3D printing), Cranial opened a new manufacturing plant to support future growth initiatives.